Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Biodesix (BDSX) Net Income towards Common Stockholders (2019 - 2025)

Historic Net Income towards Common Stockholders for Biodesix (BDSX) over the last 7 years, with Q3 2025 value amounting to -$9.1 million.

  • Biodesix's Net Income towards Common Stockholders rose 1417.42% to -$9.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$40.0 million, marking a year-over-year increase of 824.26%. This contributed to the annual value of -$42.8 million for FY2024, which is 1596.37% up from last year.
  • Biodesix's Net Income towards Common Stockholders amounted to -$9.1 million in Q3 2025, which was up 1417.42% from -$11.6 million recorded in Q2 2025.
  • Over the past 5 years, Biodesix's Net Income towards Common Stockholders peaked at -$6.2 million during Q1 2021, and registered a low of -$18.8 million during Q1 2023.
  • Over the past 5 years, Biodesix's median Net Income towards Common Stockholders value was -$11.6 million (recorded in 2025), while the average stood at -$12.1 million.
  • Per our database at Business Quant, Biodesix's Net Income towards Common Stockholders tumbled by 29234.66% in 2021 and then skyrocketed by 4404.5% in 2023.
  • Biodesix's Net Income towards Common Stockholders (Quarter) stood at -$13.2 million in 2021, then dropped by 24.78% to -$16.4 million in 2022, then soared by 44.05% to -$9.2 million in 2023, then increased by 8.67% to -$8.4 million in 2024, then fell by 8.62% to -$9.1 million in 2025.
  • Its Net Income towards Common Stockholders stands at -$9.1 million for Q3 2025, versus -$11.6 million for Q2 2025 and -$10.8 million for Q1 2025.